Studies how often restless legs syndrome occurs in Thai people with Parkinson's disease
Observes restless leg symptoms in adults with Parkinson's disease, without giving any treatment.
Key facts
- Who runs it
- Siriraj Hospital
- Where
- Bangkok, ThailandSee the site
- Trial code
- Registry title
- Prevalence and Characteristics of Restless Leg Syndrome in Thai Patients With Parkinson's Disease
- Status
- Recruiting
- People taking part
- 310 people, planned
- Started
- 1 Dec 2024
- Expected to end
- 30 Nov 2026
- Type of study
- Observational
- Treatments tested
- Screening for symptoms of restless leg syndrome
- Record updated
- 15 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 80 with Parkinson's disease. It checks how common restless legs syndrome is among them.
- Age
- 18 to 80 years
- Sex
- All sexes can join.
- Disease stage
- Parkinson's disease that meets the UK Parkinson's Disease Society Brain Bank diagnostic criteria.
Main reasons for not taking part
- Atypical or secondary parkinsonism
- Mini-mental status exam (MMSE) score less than 24 of 30
- Restless legs syndrome caused by end-stage renal disease
- Restless legs syndrome caused by iron deficiency anemia
- Restless legs syndrome caused by pregnancy
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients with Parkinson's disease aged from 18 to 80 years who met the United Kingdom Parkinson's Disease Society (UKPDS) Brain Bank Diagnostic criteria
Who cannot take part
- Patients with secondary causes of restless leg syndrome including end-stage renal disease, iron deficiency anemia and pregnancy
- Patients with atypical or secondary parkinsonism
- Patients with Mini-mental status exam (MMSE) less than 24 of 30
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in Thailand
- Siriraj Hospital Mahidol UniversityBangkok, ThailandContact: Jindapa Srikajon, MD.Taking people
About the trial
What the trial wants to find out
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by pathologic intraneuronal alpha-synuclein-positive Lewy bodies and neuronal cell loss. The cardinal clinical symptoms and signs of PD are bradykinesia, rigidity, tremor, postural instability, and freezing attacks. The prevalence of PD increases with age, affecting 1-2% of the population over the age of 65 years, and 3% of those over 85 years.
Read full original descriptionShow less
Restless legs syndrome (RLS) represents disturbing symptoms in lower limbs that lead to the urge to move, occurring in rest periods. Movements can partially or completely relieve these abnormal feelings. In 2014, the International RLS Study Group (IRLSSG) established five mandatory criteria for the diagnosis of RLS. Several studies supported that RLS and PD may share pathophysiological mechanisms.
The group in the trial
- Patients with parkinson's disease
Treatment: Screening for symptoms of restless leg syndrome
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prevalence and Characteristics of Restless Leg Syndrome in Thai Patients With Parkinson's Disease
- Plain-language title
- Studies how often restless legs syndrome occurs in Thai people with Parkinson's diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06684782, who can take part
- Publications
- Record updated
- 15 May 2025